EUVIMEDEUVIMED entdecken
Crossref

Mitochondrial encephalopathies and myopathies: Our tertiary center's experience

Can Ozlu, Souad Messahel, Berge Minassian, Saima Kayani

European Journal of Paediatric Neurology · 2024

DOI: 10.1016/j.ejpn.2024.03.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Paediatric Neurology, 2024. Verfasst von Can Ozlu und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of Texas Southwestern Medical Center ,Dallas, TX, USA; Children's Medical Center, Dallas, TX, USA. Hauptthemen laut MEDLINE: Mitochondrial Encephalomyopathies, Mutation, DNA, Mitochondrial. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial diseases have a heterogeneous phenotype and can result from mutations in the mitochondrial or nuclear genomes, constituting a diagnostically and therapeutically challenging group of disorders. We report our center's experience with mitochondrial encephalopathies and myopathies with a cohort of 50 genetically and phenotypically diverse patients followed in the Neurology clinic over the last ten years. Seventeen patients had mitochondrial DNA mutations, presented over a wide range of ages with seizures, feeding difficulties, extraocular movements abnormalities, and had high rates of stroke-like episodes and regression. Twenty-seven patients had nuclear DNA mutations, presented early in life with feeding difficulty, failure-to-thrive, and seizures, and had high proportions of developmental delay, wheelchair dependence, spine abnormalities and dystonia. In six patients, a mutation could not be identified, but they were included for having mitochondrial disease confirmed by histopathology, enzyme analysis and clinical features. These patients had similar characteristics to patients with nuclear DNA mutations, suggesting missed underlying mutations in the nuclear genome. Management was variable among patients, but outcomes were universally poor with severe disability in all cases. Therapeutic entryways through elucidation of disease pathways and remaining unknown genes are acutely needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitochondrial EncephalomyopathiesMutationDNA, MitochondrialHumansMaleFemaleChildChild, PreschoolInfantAdolescentAdultYoung AdultTertiary Care CentersMitochondrial Myopathies

Stichwörter der Autor:innen

CohortEncephalopathyMitochondrial diseaseMitochondrial gene mutationMyopathy

Substanzen

DNA, Mitochondrial

Autor:innen und Institutionen

  • University of Texas Southwestern Medical Center ,Dallas, TX, USA; Children's Medical Center, Dallas, TX, USA.
  • Elpida Therapeutics, Encino, CA, USA.
  • University of Texas Southwestern Medical Center ,Dallas, TX, USA; Children's Medical Center, Dallas, TX, USA. Electronic address: saima.kayani@utsouthwestern.edu.

Zitieren

APA

Ozlu, C., Messahel, S., Minassian, B., & Kayani, S. (2024). Mitochondrial encephalopathies and myopathies: Our tertiary center's experience. European Journal of Paediatric Neurology. https://doi.org/10.1016/j.ejpn.2024.03.005

Vancouver

Ozlu C, Messahel S, Minassian B, Kayani S. Mitochondrial encephalopathies and myopathies: Our tertiary center's experience. European Journal of Paediatric Neurology. 2024. doi:10.1016/j.ejpn.2024.03.005

BibTeX
@article{Ozlu2024,
  author = {Ozlu, Can and Messahel, Souad and Minassian, Berge and Kayani, Saima},
  title = {Mitochondrial encephalopathies and myopathies: Our tertiary center's experience},
  journal = {European Journal of Paediatric Neurology},
  year = {2024},
  doi = {10.1016/j.ejpn.2024.03.005}
}
Kostenlos starten →